Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 15 citing articles:

Bridging Targeted and Untargeted Mass Spectrometry-Based Metabolomics via Hybrid Approaches
Li Chen, Fanyi Zhong, Jiangjiang Zhu
Metabolites (2020) Vol. 10, Iss. 9, pp. 348-348
Open Access | Times Cited: 66
Simultaneous Quantitation and Discovery (SQUAD) Analysis: Combining the Best of Targeted and Untargeted Mass Spectrometry-Based Metabolomics
Bashar Amer, Rahul Deshpande, Susan S. Bird
Metabolites (2023) Vol. 13, Iss. 5, pp. 648-648
Open Access | Times Cited: 21
Application of intelligent tongue image analysis in Conjunction with microbiomes in the diagnosis of MAFLD
Shixuan Dai, Xiaojing Guo, Shi Liu, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e29269-e29269
Open Access | Times Cited: 5
Longitudinal association of metabolic dysfunction-associated fatty liver disease, serum metabolites, with cognitive function trajectories
Anxin Wang, Xue Tian, Qiqi Deng, et al.
npj Metabolic Health and Disease (2025) Vol. 3, Iss. 1
Open Access
Current Therapeutical Approaches Targeting Lipid Metabolism in NAFLD
Manuela Vitulo, Elisa Gnodi, Giulia Rosini, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12748-12748
Open Access | Times Cited: 11
Characterization of microbiome and metabolite analyses in patients with metabolic associated fatty liver disease and type II diabetes mellitus
Qiuping Yang, Leisheng Zhang, Qian Li, et al.
BMC Microbiology (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Metabolomic Hallmarks of Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease
Diren Beyoğlu, Yury Popov, Jeffrey R. Idle
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12809-12809
Open Access | Times Cited: 2
Vitamin B6 Metabolic Pathway is Involved in the Pathogenesis of Liver Diseases via Multi-Omics Analysis
Meihua Mei, Danping Liu, Xiuxin Tang, et al.
Journal of Hepatocellular Carcinoma (2022) Vol. Volume 9, pp. 729-750
Open Access | Times Cited: 11
Integrated analysis of the transcriptome and its interaction with the metabolome in metabolic associated fatty liver disease: Gut microbiome signatures, correlation networks, and effect of PNPLA3 genotype
María Florencia Mascardi, Flavia Noelia Mazzini, Bárbara Suárez, et al.
PROTEOMICS (2023) Vol. 23, Iss. 18
Closed Access | Times Cited: 6
Single Nucleotide Polymorphism of Genes Associated with Metabolic Fatty Liver Disease
Tong Mu, Linrui Peng, Xinglei Xie, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-6
Open Access | Times Cited: 10
Application of metabolomics in the diagnosis of non-alcoholic fatty liver disease and the treatment of traditional Chinese medicine
Mingmei Shao, Yifei Lü, Hongjiao Xiang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 7
Comprehensive Phenotyping in Inflammatory Bowel Disease: Search for Biomarker Algorithms in the Transkingdom Interactions Context
Ayelén Daiana Rosso, Pablo Aguilera, Sofía Quesada, et al.
Microorganisms (2022) Vol. 10, Iss. 11, pp. 2190-2190
Open Access | Times Cited: 3
Serum metabolomics-based heterogeneities and screening strategy for metabolic dysfunction-associated fatty liver disease (MAFLD)
Shao Li, Jing Liu, Yu Song, et al.
Clinica Chimica Acta (2022) Vol. 538, pp. 203-210
Open Access | Times Cited: 3
Metabolomics at the cutting edge of risk prediction of MASLD
En Ying Tan, Mark Muthiah, Arun J. Sanyal
Cell Reports Medicine (2024), pp. 101853-101853
Closed Access
Epidemiology and risk factors for histopathologic characteristics of non‐alcoholic fatty liver disease in South America
Joseph Akambase, Jhon Prieto, Ângelo Zambam de Mattos, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 5, pp. 526-536
Closed Access | Times Cited: 1
Metabolic-associated fatty liver disease from childhood to adulthood: State of art and future directions
Francesca Lanzaro, Stefano Guarino, Elisabetta D'Addio, et al.
World Journal of Hepatology (2022) Vol. 14, Iss. 6, pp. 1087-1098
Open Access | Times Cited: 2
Page 1

Scroll to top